Zynerba Pharmaceuticals

(NASDAQ: ZYNE)
Healthcare  |  Biotechnology
11.30 0.1 0.89%
Stock Price | Aug. 19, 2019, 4 p.m.
1 Follower
Bid: 0.0
Ask: 0.0
Prev. Close: 11.2
52 Week Low: 2.75
52 Week High: 16.47
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 02/23/18

26 Comments
1 year ago

Premium Cannabis Stocks Review - AM Edition 02/21/18

23 Comments
1 year ago

Premium Cannabis Stocks Review - AM Edition 02/20/18

106 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 02/20/18

113 Comments
1 year ago

Premium Cannabis Stocks Review - Pre-Market Edition 02/15/18

3 Comments
1 year ago

Premium Flying High Buy 02/14/18

50 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 01/16/18

20 Comments
1 year ago

Premium Cannabis Stocks Review - AM Edition 01/10/18

31 Comments
1 year ago

Premium Cannabis Stocks Review - Pre-Market Edition 01/10/18

37 Comments
1 year ago

Premium Cannabis Stocks Review - Pre-Market Edition 01/09/18

19 Comments
1 year ago